Fundacion Oncosur
7 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Talazoparib Plus Enzalutamide After Progression to Abiraterone in Metastatic Prostate Cancer: (TEAM PC) (NCT06582628) | Fundacion Oncosur | 2024-07-05 |
| Pembrolizumab, Carboplatin and Cabazitaxel in Aggressive Metastatic Castration Resistant Prostate Cancer (PEAPOD_FOS) (NCT05563558) | Fundacion Oncosur | 2023-05-05 |
| Palbociclib and Binimetinib in Advanced Triple Negative Breast Cancer (NCT04494958) | Fundacion Oncosur | 2020-11-18 |
| Study to Assess Safety,Tolerability,Efficacy of PM01183 and Atezolizumab in Patients w/ Advanced Small Cell Lung Cancer. (NCT04253145) | Fundacion Oncosur | 2019-12-13 |
| Cabozantinib Treatment Prior to Cytoreductive Nephrectomy in Patients With Advanced or Metastatic Renal Cells Cancer (NCT06377722) | Fundacion Oncosur | 2018-11-01 |
Track Fundacion Oncosur automatically
Every clearance here is in the API, with alerts when new ones post.